BioSpace News Archive

Biotech Beach

MingSight Completes a New Round of Financing to Accelerate Clinical Development in Chronic Lymphocytic Leukemia and Diabetic Macular Edema

MingSight Pharmaceuticals announced today the close of a pre-Series B round of $20M, led by Kaitai Capital.

November 12, 2021
·
4 min read
Business

POINT Biopharma Reports Third Quarter 2021 Financial Results and Provides Business Update

POINT Biopharma Global Inc today announced financial results for the third quarter ended September 30, 2021 and provided a business update.

November 12, 2021
·
13 min read
BioForest

Silverback Therapeutics Presents Preclinical Data for SBT8230 at AASLD The Liver Meeting 2021

Silverback Therapeutics, Inc. today announced the presentation of preclinical data for SBT8230 at the American Association for the Study of Liver Diseases

November 12, 2021
·
4 min read
Pharm Country

Avenue Therapeutics Announces Closing of Public Offering of Common Stock - Nov 12, 2021

Avenue Therapeutics, Inc., a company focused on the development of intravenous tramadol for the U.S. market, announced the closing of its public offering of 1,946,787 shares of common stock at a public offering price of $1.34.

November 12, 2021
·
3 min read
Lone Star Bio

Lantern Pharma to Host Virtual KOL Event on the Potential Treatment of Pancreatic Cancer with Drug Candidate LP-184 on November 18th, World Pancreatic Cancer Day

Lantern Pharma (NASDAQ: LTRN), today announced it will host a virtual Key Opinion Leader (KOL) event regarding the potential treatment of pancreatic cancer utilizing Lantern Pharma’s drug candidate LP-184, on World Pancreatic Cancer Day.

November 12, 2021
·
6 min read
Pharm Country

Regeneron Antibody Cocktail Approved by European Commission to Treat and Prevent COVID-19

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the European Commission (EC) has approved the casirivimab and imdevimab antibody cocktail, known as REGEN-COV® in the U.S. and Ronapreve™ in the European Union (EU) and other countries.

November 12, 2021
·
22 min read
Pharm Country

Autoimmune Registry Annual Meeting on 12/15/2021 hosts panel with 5 Clinical Research Participants

On Wednesday, December 15th from 6-8pm EST the Autoimmune Registry will hold its Annual Research Meeting. Our theme this year is “Patient to Patient on Clinical Research.”

November 12, 2021
·
1 min read
Pharm Country

NRx Pharmaceutical’s Chairman and Chief Executive Officer Jonathan Javitt to Present Company Business Update at H.C. Wainwright 7th Annual Israel Conference

NRx Pharmaceuticals, a clinical-stage, biopharmaceutical company, announced its Chairman of the Board and Chief Executive Officer, Jonathan Javitt, will be presenting updates to the Company’s business at the H.C. Wainwright 7th Annual Israel Virtual Conference.

November 12, 2021
·
2 min read
Drug Development

Carisma Therapeutics Presents Data from Phase I Clinical Trial of CT-0508, A HER2 Targeted CAR-Macrophage

Carisma Therapeutics Inc., presented today for the first time preliminary findings from the landmark Phase 1 multi-center clinical trial of CT-0508, a human epidermal growth factor receptor 2 (HER2) targeted chimeric antigen receptor macrophage (CAR-M) .

November 12, 2021
·
3 min read
Business

Astrotech Reports First Quarter of Fiscal Year 2022 Financial Results

Astrotech Corporation (Nasdaq: ASTC) reported its financial results for the first quarter of fiscal year 2022, which ended September 30, 2021.

November 12, 2021
·
8 min read